Agile Therapeutics, Inc. IPO Research Information

Agile Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Agile Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Agile Therapeutics, Inc.	AGRX - NASDAQ	$6.00-$6.00	$6.00	$5.50	9.2 million	5/23/2014
Underwriter(s): RBC Capital Markets, William Blair
Co-Manager(s): Cantor Fitzgerald & Co., Janney Montgomery Scott
Industry: Health Care
Filing(s): Filed 2014-03-17 Terms Added 2014-05-09 Amended Terms 2014-05-22

Agile Therapeutics, Inc. Quote & Chart - Click for current quote - AGRX

About Agile Therapeutics, Inc. (adapted from Agile Therapeutics, Inc. prospectus):
They are a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "AGRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.